机译:随机,安慰剂对照,FosapRepitant,Ondansetron,Dexamethasone(喜欢的)与Fond Plus Olanzapine(FONE-O)进行血液学恶性肿瘤患者的血液学恶性肿瘤患者呕吐,ondansetron,ondansetron(Fond-O)的试验。接受高均匀化疗和造血细胞移植的血液学恶性肿瘤患者 方案:FOND-O试验
Department of Clinical and Administrative Pharmacy University of Georgia College of Pharmacy;
Department of Pharmacy Indiana University;
Geisinger Enterprise Pharmacy Center for Pharmacy Innovations and Outcomes;
Department of Pharmacy Augusta University Medical Center;
Department of Medicine Division of Hematology and Medical Oncology;
Department of Pharmacotherapy and Translational Research University of Florida College of Pharmacy;
Chemotherapy-induced; Fosaprepitant; Hematopoietic; Nausea; Olanzapine; Prevention; Prophylaxis; Vomiting;
机译:随机,安慰剂对照,FosapRepitant,Ondansetron,Dexamethasone(喜欢的)与Fond Plus Olanzapine(FONE-O)进行血液学恶性肿瘤患者的血液学恶性肿瘤患者呕吐,ondansetron,ondansetron(Fond-O)的试验。接受高均匀化疗和造血细胞移植的血液学恶性肿瘤患者 方案:FOND-O试验
机译:Ramosetron与Ondansetron联合Aprepitant和地塞米松预防高度致呕性化疗所致的恶心和呕吐:多中心,随机III期试验,KCSG PC10-21
机译:Ramosetron与Ondansetron联合Aprepitant和地塞米松预防高度致呕性化疗所致的恶心和呕吐:多中心,随机III期试验,KCSG PC10-21
机译:APF530与昂丹司琼分别采用一种指南推荐的三药方案用于预防因蒽环类抗生素加环磷酰胺的高度致呕性化疗方案而导致的化疗引起的恶心和呕吐:III期随机MAGIC试验的事后亚组分析
机译:随机,安慰剂对照,FosapRepitant,Ondansetron,Dexamethasone(喜欢的)与Fond Plus Olanzapine(FONE-O)进行血液学恶性肿瘤患者的血液学恶性肿瘤患者呕吐,ondansetron,ondansetron(Fond-O)的试验。接受高均匀化疗和造血细胞移植的血液学恶性肿瘤患者方案:FOND-O试验